🚀 AI-picked stocks soar in May. PRFT is +55%—in just 16 days! Don’t miss June’s top picks.Unlock full list

Jim Cramer Rejects Illumina As 'It's Not Well-Run,' Recommends Buying This Tech Stock 'Right Here, Right Now'

Published 30/04/2024, 14:13
© Reuters.  Jim Cramer Rejects Illumina As 'It's Not Well-Run,' Recommends Buying This Tech Stock 'Right Here, Right Now'
BAC
-
ILMN
-
PANW
-
CGC
-
DT
-

Benzinga - by Avi Kapoor, Benzinga Staff Writer.

On CNBC's Mad Money Lightning Round,” Jim Cramer said Dynatrace, Inc. (NYSE:DT) is “very expensive” stock, and he is not going to recommend it.

On April 19, TD Cowen analyst Andrew Sherman maintained Dynatrace with a Buy and lowered the price target from $62 to $58.

Canopy Growth Corporation (NASDAQ:CGC) is the “best of the pot stocks,” Cramer said, “We don't think it's worth all that much, but we do think it's the best of that lot.”

On April 18, Canopy Growth announced that CBI exchanged 17,149,925 common shares in the capital of the company for exchangeable shares for no consideration

When asked about BrightSpring Health Services, Inc. (NASDAQ:BTSG), he said, “That short position is too big for me to just say, ‘I'd buy that stock.' Someone may know something that I don't.”

BrightSpring Health Services is projected to release its first quarter 2024 financial results on Thursday, May 2.

Illumina, Inc. (NASDAQ:ILMN) is a “good company, but it's not well-run,” Cramer said, “I don't want to own a company that's poorly-run because then the stock gets hurt.”

Illumina is expected to issue results for the first quarter 2024 after the closing bell on Thursday, May 2.

The “Mad Money” host said Bank of America Corporation (NASDAQ:BAC) is not his favorite of the big banks. “I do prefer other banks,” he added.

Bank of America reported better-than-expected earnings for its first quarter on April 16.

Cramer recommended buying Palo Alto Networks, Inc. (NASDAQ:PANW). “I would be a buyer of Palo Alto right here, right now,” he said.

On April 18, Keybanc analyst Michael Turits maintained Palo Alto with an Overweight and lowered the price target from $380 to $355.

Price Action:

  • Canopy Growth shares fell 6.6% to settle at $8.32 on Monday.
  • Illumina shares rose 2% to close at $124.73 on Monday.
  • Bank of America shares fell 0.7% to settle at $37.55 on Monday.
  • Dynatrace shares fell 1.3% to settle at $46.51 during Monday's session.
  • BrightSpring Health Services shares gained 3.1% to close at $10.91 on Monday.
  • Palo Alto Networks shares rose 0.7% to settle at $293.41 during Monday's session.
Read Next: Over $3M Bet On Steel Connect? Check Out These 4 Stocks Insiders Are Buying

Photo: Shutterstock

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.